Last reviewed · How we verify

combination oral and topical vitamin D

Indonesia University · FDA-approved active Small molecule Quality 5/100

combination oral and topical vitamin D is a Small molecule drug developed by Indonesia University. It is currently FDA-approved.

At a glance

Generic namecombination oral and topical vitamin D
SponsorIndonesia University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about combination oral and topical vitamin D

What is combination oral and topical vitamin D?

combination oral and topical vitamin D is a Small molecule drug developed by Indonesia University.

Who makes combination oral and topical vitamin D?

combination oral and topical vitamin D is developed and marketed by Indonesia University (see full Indonesia University pipeline at /company/indonesia-university).

What development phase is combination oral and topical vitamin D in?

combination oral and topical vitamin D is FDA-approved (marketed).

Related